Summary & Overview
HCPCS C9808: Nerve Cryoablation Probe for Non-Opioid Post-Surgical Pain
HCPCS Level II code C9808 represents a nerve cryoablation probe, including the probe and all disposable system components, designated as a qualifying non-opioid medical device for post-surgical pain relief under section 4135 of the CAA, 2023. As non-opioid technologies gain attention for perioperative pain management, this device-level code enables clearer identification of cryoablation probes used in that context. Nationally, accurate coding matters for claims processing, coverage determinations, and tracking uptake of non-opioid pain interventions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coding intent and clinical context, typical sites of service, and the policy-relevant framing tied to the CAA, 2023 requirement for qualifying non-opioid medical devices. The publication outlines benchmarks for coverage language and reimbursement pathways, highlights common billing modifiers used with device and procedure claims, and summarizes implications for facility and device suppliers.
The piece also situates C9808 within broader trends in non-opioid post-surgical pain management and administrative practices for device billing. Data not available in the input is noted where specific payer policies, associated taxonomies, and ICD-10 pairings would normally be described.
Billing Code Overview
HCPCS Level II code C9808 describes a nerve cryoablation probe, including the probe and all disposable system components for a qualifying non-opioid medical device intended for post-surgical pain relief under section 4135 of the CAA, 2023. The code covers the device and disposables as a bundled supply.
Service Type: Device supply for procedural nerve cryoablation
Typical Site of Service: Hospital outpatient, ambulatory surgical center, or other procedural setting where cryoablation is performed
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old adult who underwent total knee arthroplasty and is experiencing significant postoperative pain despite standard multimodal analgesia and a desire to avoid or minimize opioid use. The orthopedic surgical team arranges placement of a qualifying Medicare non-opioid nerve cryoablation probe (C9808) targeting the infrapatellar branch of the saphenous nerve or adjacent sensory branches for prolonged postoperative analgesia. The workflow includes pre-procedure evaluation by a pain management physician or anesthesiologist; verification of device eligibility under the Consolidated Appropriations Act section 4135 for non-opioid devices; informed consent emphasizing non-opioid modality and anticipated duration of analgesia; ultrasound or fluoroscopic localization of the target peripheral sensory nerve; sterile preparation and local anesthesia; percutaneous insertion and activation of the disposable cryoablation probe system (including probe and all disposable components covered by C9808); immediate post-procedure monitoring for hemodynamic stability and sensory/motor assessment; documentation of device model, lot number, laterality, targeted nerve, technical details, and any immediate complications. Typical sites of service are the hospital inpatient or outpatient surgical suite, ambulatory surgery center, or hospital outpatient department. Follow-up includes routine surgical postoperative visits and remote pain check-ins to assess analgesic efficacy and potential neuropathic symptoms.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|